Effects of peptide YY on CCK/CCK antagonist interactions in cerulein-induced pancreatic injury.
Tito
J M
JM
Mary Imogene Bassett Hospital, Cooperstown, New York 13326, USA.
Rudnicki
M
M
Robinson
D C
DC
Guiney
W B
WB
Adrian
T E
TE
Gold
M S
MS
D000681:Amylases / Q000378:metabolism; D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology*; D002108:Ceruletide / Q000494:pharmacology; D002766:Cholecystokinin / Q000037:antagonists & inhibitors; D020109:Devazepide; D010179:Pancreas / Q000187:drug effects*; D019894:Peptide YY; D010455:Peptides / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors*
D001570:Benzodiazepinones; D010455:Peptides; D011949:Receptors, Cholecystokinin; D019894:Peptide YY; D002108:Ceruletide; D002766:Cholecystokinin; D000681:Amylases; D020109:Devazepide